|Articles|October 1, 2016
- BioPharm International-10-01-2016
- Volume 29
- Issue 10
BioPharm International, October 2016 Issue (PDF)
Click the title above to open the BioPharm International October 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Defining Risk Assessment of Aseptic Processesabout 9 years ago
Real Time Continuous Microbiological Monitoringabout 9 years ago
Optimizing Temperature Control for Biopharmaceuticalsabout 9 years ago
HPLE Sugars Improve Stability and Drug Productabout 9 years ago
Calling All Authorsabout 9 years ago
Multiparticulate technologies hot for controlled releaseabout 9 years ago
New Drug-Delivery Methods: From Concept to Patientabout 9 years ago
Manufacturers Face Major Changes under PDUFA VIabout 9 years ago
Fill/Finish OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
